215 related articles for article (PubMed ID: 24299099)
1. Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age.
Fielding JE; Kelly HA; Mercer GN; Glass K
Influenza Other Respir Viruses; 2014 Mar; 8(2):142-50. PubMed ID: 24299099
[TBL] [Abstract][Full Text] [Related]
2. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
[TBL] [Abstract][Full Text] [Related]
3. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
[TBL] [Abstract][Full Text] [Related]
5. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
[TBL] [Abstract][Full Text] [Related]
6. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011.
Suess T; Remschmidt C; Schink SB; Schweiger B; Heider A; Milde J; Nitsche A; Schroeder K; Doellinger J; Braun C; Haas W; Krause G; Buchholz U
PLoS One; 2012; 7(12):e51653. PubMed ID: 23240050
[TBL] [Abstract][Full Text] [Related]
7. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
8. Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection--a retrospective comparative analysis.
Redlberger-Fritz M; Hirk S; Buchinger D; Haberl R; Hell M; Perkmann-Nagele N; Kundi M; Popow-Kraupp T
J Med Virol; 2014 Jun; 86(6):1048-55. PubMed ID: 24615722
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
10. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
[TBL] [Abstract][Full Text] [Related]
11. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
[TBL] [Abstract][Full Text] [Related]
12. Duration of viral shedding in hospitalized patients infected with pandemic H1N1.
Meschi S; Selleri M; Lalle E; Bordi L; Valli MB; Ferraro F; Ippolito G; Petrosillo N; Lauria FN; Capobianchi MR
BMC Infect Dis; 2011 May; 11():140. PubMed ID: 21605362
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
14. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
[TBL] [Abstract][Full Text] [Related]
15. Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children.
Feiterna-Sperling C; Edelmann A; Nickel R; Magdorf K; Bergmann F; Rautenberg P; Schweiger B; Wahn V; Krüger DH; Hofmann J
Clin Infect Dis; 2010 Dec; 51(11):e90-4. PubMed ID: 21039216
[TBL] [Abstract][Full Text] [Related]
16. Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany.
Reuss A; Dehnert M; Buda S; Haas W
Influenza Other Respir Viruses; 2013 Nov; 7(6):1427-32. PubMed ID: 23957666
[TBL] [Abstract][Full Text] [Related]
17. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
[TBL] [Abstract][Full Text] [Related]
18. Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis.
Sun Y; Wang Q; Yang G; Lin C; Zhang Y; Yang P
Infect Dis (Lond); 2016; 48(11-12):813-22. PubMed ID: 27385315
[TBL] [Abstract][Full Text] [Related]
19. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
[TBL] [Abstract][Full Text] [Related]
20. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
